As a type of chemotherapy treatment, Iressa® (gefitinib) is approved to treat non-small cell lung cancer in adults. It comes as a tablet that is usually taken once a day. Side effects are common and may include nausea, diarrhea, and acne.
If your healthcare provider recommends chemotherapy treatment with Iressa, he or she will need information on your medical history and any other medications, vitamins, or supplements you are using. By reviewing these details, you can help minimize your risk for potentially dangerous drug interactions or other serious complications. For example, Iressa may not be safe for people who have problems with their liver, kidneys, or lungs.
(To learn more about this chemotherapy drug, click Iressa. This full-length article covers more information, including details on how the medicine works, what to expect during treatment, and other important warnings and precautions.)
Written by/reviewed by: Arthur Schoenstadt, MD
Last reviewed by: ArthurSchoenstadt, MD
List of references (click here):
Iressa [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals, LP;2005 June.
Food and Drug Administration, Center for Drug Evaluation and Research. Drugs@FDA. FDA Approved Drug Products. FDA Web site. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/. Accessed October 7, 2012.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click